Evidence map›Paper›PMID 32253821›Full record

ArticleCancer medicine2020

Impact of chronic diseases on effect of breast cancer screening.

Anna-Belle Beau, George M Napolitano, Marianne Ewertz, Ilse Vejborg, Walter Schwartz, Per K Andersen, Elsebeth Lynge

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Anna-Belle BeauSection of Environmental Health, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-4631-100X
George M NapolitanoSection of Environmental Health, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Marianne EwertzDepartment of Oncology, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
Ilse VejborgDepartment of Radiology, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.
Walter SchwartzMammography Centre, Odense University Hospital, Odense, Denmark.
Per K AndersenSection of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Elsebeth LyngeCentre for Epidemiological Research, Nykøbing Falster Hospital, Nykøbing Falster, Denmark.
University of Copenhagen · DKCopenhagen University Hospital · DKOdense University Hospital · DKSjællands Universitetshospital, Nykøbing F. · DKUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough breast cancer screening reduces breast cancer mortality at the population level, subgroups of women may benefit differently. We investigated the impact of health status on the effect of breast cancer screening.

methodsThe study included 181 299 women invited in two population-based screening programs in Denmark and 1 526 446 control subjects, followed from April 1981 to December 2014. Poisson regressions were used to compare the observed breast cancer mortality rate in women invited to screening with the expected rate in the absence of screening among women with and without chronic diseases. Chronic diseases were defined as any diagnosis in the Charlson Comorbidity Index during 4 years before the first invitation to screening.

resultsAlmost 10% of women had chronic diseases before first invitation to screening. Whereas we observed a reduction in breast cancer mortality following invitation to screening of 28% (95% CI, 20% to 35%) among women without chronic diseases, only a 7% (95% CI, -39% to 37%) reduction was seen for women with chronic diseases (P-value for interaction = .22). For participants, the reduction, corrected for selection bias, was 35% (95% CI 16% to 49%) for women without, and 4% (95% CI -146% to 62%) for women with chronic diseases (P-value for interaction = .43).

conclusionOur data indicate a marginal effect of mammography screening on breast cancer mortality in women with chronic diseases. If our results are confirmed in other populations, the presence of chronic diseases will be an important factor to take into consideration in personalized screening.

Indexed as

Health StatusAgedBreast NeoplasmsCase-Control StudiesChronic DiseaseEarly Detection of CancerFemaleFollow-Up StudiesHumansMammographyMiddle AgedPrognosisSurvival Ratebreast cancer mortality reductionBreast cancer screeningchronic diseasesimpact of screeningpersonalized screeningregister-based study

Identifiers

PMID32253821
PMCPMC7286470
OpenAlexW3014587642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.